PubRank

John A Petros

Author PubWeight™ 50.73‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 In vivo molecular and cellular imaging with quantum dots. Curr Opin Biotechnol 2005 3.92
2 Formalin disinfection of biopsy needle minimizes the risk of sepsis following prostate biopsy. J Urol 2013 2.81
3 XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH. Urology 2010 2.55
4 Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry. Nat Protoc 2007 2.45
5 Increased Nox1 and hydrogen peroxide in prostate cancer. Prostate 2005 2.19
6 North American white mitochondrial haplogroups in prostate and renal cancer. J Urol 2006 2.13
7 Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma. Cancer Res 2006 2.05
8 Epididymal sparing bilateral simple orchiectomy with epididymoplasty: preservation of esthetics and body image. J Urol 2005 1.54
9 Molecular classification of renal tumors by gene expression profiling. J Mol Diagn 2005 1.52
10 Molecular mapping of tumor heterogeneity on clinical tissue specimens with multiplexed quantum dots. ACS Nano 2010 1.31
11 Protein-coding and microRNA biomarkers of recurrence of prostate cancer following radical prostatectomy. Am J Pathol 2011 1.24
12 Loss of HOXC6 expression induces apoptosis in prostate cancer cells. Oncogene 2005 1.23
13 Oxidative stress induces ADAM9 protein expression in human prostate cancer cells. Cancer Res 2006 1.23
14 Cancer-specific loss of beta-defensin 1 in renal and prostatic carcinomas. Lab Invest 2003 1.22
15 Role of transrectal ultrasonography in diagnosis and treatment of retained Foley catheter. Urology 2005 1.21
16 Spermatic cord anesthesia block for scrotal procedures in outpatient clinic setting. J Urol 2004 1.20
17 PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer. Cancer Res 2004 1.15
18 Dilutional hyponatremia of TURP syndrome: a historical event in the 21st century. Urology 2004 1.09
19 Beta defensin-1, parvalbumin, and vimentin: a panel of diagnostic immunohistochemical markers for renal tumors derived from gene expression profiling studies using cDNA microarrays. Am J Surg Pathol 2003 1.05
20 Mitochondrial NADH-dehydrogenase subunit 3 (ND3) polymorphism (A10398G) and sporadic breast cancer in Poland. Breast Cancer Res Treat 2009 1.05
21 Thrombocytosis is associated with a significant increase in the cancer specific death rate after radical nephrectomy. J Urol 2002 1.05
22 Pelvic nephroureterectomy for renal cell carcinoma in an ectopic kidney. Case Rep Oncol Med 2012 1.02
23 Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment. Prostate 2009 1.01
24 Endoscopic enucleation of leiomyoma of the bladder. Urol Int 2005 0.97
25 Sequence variation in the mitochondrial gene cytochrome c oxidase subunit I and prostate cancer in African American men. Prostate 2009 0.92
26 Radical prostatectomy for clinical T4 prostate cancer. Cancer 2006 0.89
27 Current trends in molecular classification of adult renal tumors. Urology 2006 0.88
28 Increased low density lipoprotein and increased likelihood of positive prostate biopsy in black americans. J Urol 2009 0.88
29 Nox1 expression determines cellular reactive oxygen and modulates c-fos-induced growth factor, interleukin-8, and Cav-1. Am J Pathol 2007 0.87
30 The value of digital rectal examination as a predictor of prostate cancer diagnosis among United States Veterans referred for prostate biopsy. Cancer Detect Prev 2006 0.84
31 Mitochondrial genotype and breast cancer predisposition. Oncol Rep 2010 0.82
32 An inherited heteroplasmic mutation in mitochondrial gene COI in a patient with prostate cancer alters reactive oxygen, reactive nitrogen and proliferation. Biomed Res Int 2012 0.82
33 The fate of the medically castrated testis: expectation versus reality. J Urol 2004 0.81
34 Mitochondrial NADH-dehydrogenase polymorphisms as sporadic breast cancer risk factor. Oncol Rep 2010 0.81
35 Surgical margin and Gleason score as predictors of postoperative recurrence in prostate cancer with or without chromosome 8p allelic imbalance. Prostate 2004 0.81
36 Mitochondrial Cytochrome c Oxidase subunit 1 Sequence Variation in Prostate Cancer. Scientifica (Cairo) 2012 0.80
37 Comparison of 12-core versus 8-core prostate biopsy: multivariate analysis of large series of US veterans. Urology 2011 0.79
38 Automated sequencing of complete mitochondrial genomes from laser-capture microdissected samples. Biotechniques 2003 0.77
39 Sentinel lymph node mapping in prostate cancer: opportunities remain to identify truly positive nodes. J Urol 2006 0.77
40 Embryonic stem-cell research. N Engl J Med 2004 0.75
41 Pulsatile mass in the scrotum in a man with the Leriche syndrome. J Urol 2002 0.75
42 A +20% adjustment in the computed tomography measured ureteral length is an accurate predictor of true ureteral length before ureteral stent placement. J Endourol 2013 0.75